NEW YORK (GenomeWeb News) – UK miniature mass spectrometry firm Microsaic Systems today announced a conditional placing of about 3.9 million shares to raise £1.6 million ($2.5 million).

The shares are priced at 40 pence per share. The conditional placing, which was oversubscribed, is with certain existing institutional and other investors. The placing is conditional on the passage of certain resolutions to be proposed at Microsaic's annual general meeting to be held on May 30.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.